SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-99-000004
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
7
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 205138
2 LICENSE AGREEMENT BETWEEN BLOCK DRUG COMPANY EX-10.17 57220
3 SUBSIDIARIES OF THE REGISTRANT EX-21 183
4 CONSENT OF INDEPENDENT CERTIFIED PUBLIC EX-23.1 993
5 CONSENT OF INDEPENDENT CERTIFIED PUBLIC EX-23.2 1908
6 CONSENT OF INDEPENDENT CERTIFIED PUBLIC EX-23.3 667
7 FDS EX-27 1708
  Complete submission text file 0000318306-99-000004.txt   270237
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-09314 | Film No.: 99583547
SIC: 2834 Pharmaceutical Preparations